Friday, 6. November 2026 · Next update: 10:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
🍾 Beverages · Next Month

Fever-Tree Drinks plc (AIM: FEVR) reports H1 2026 organic revenue growth above 3.0% year-on-year (expected approx. September 9, 2026)

Hit ✦ AI-generated prediction Published on 18. July 2026 · Predicted for 9. September 2026 · Based on: Historical Cycle
Probability
52%

Fever-Tree achieved approx. 2–3% organic growth in FY 2025 — a recovery after the post-Covid US trade channel destocking. For H1 2026, the following factors support acceleration: (1) US hospitality recovery and inventory normalisation completed; (2) Europe's on-trade season (summer 2026) benefits from Burnham's UK staycation effect; (3) Asia-Pacific (esp. Australia, Japan) growing double-digit. Analyst consensus HSBC/Peel Hunt is ~3–4% organic for H1 2026. A result >3% is the base case but not certain: FX headwind (GBP strength) and US tariff recovery slightly dent USD-denominated imports. Results calendar: Fever-Tree typically reports H1 in early September.

Data basis for this prediction
  • Fever-Tree FY2025 Results: organisches Umsatzwachstum ~2–3 % (veröffentlicht März 2026)
  • HSBC / Peel Hunt: FEVR H1-2026 Konsensschätzung ~3–4 % organisch (Stand Juni 2026)
  • Bloomberg: FEVR 12-Monats-Konsens organisches Wachstum ~3,2 % (Stand Juli 2026)

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit
Fever-Tree veröffentlichte seine H1-2026-Ergebnisse am 10. September 2026 (einen Tag nach dem prognostizierten Datum). Die Markenerlöse stiegen um 8 % zu konstanten Wechselkursen auf £183,6 Mio. – deutlich über der Hürde von >3 % organischem Wachstum. Das Wachstum war regional breit abgestützt: USA +11 %, Europa +10 %, UK +3 %, Rest of World +5–6 %. Das Adjusted EBITDA stieg um 9 % auf £20,1 Mio. Der heiße Sommer in UK/Europa (Burnham-Staycation-Effekt), die abgeschlossene US-Lagernormalisierung und die Expansion im Nicht-Tonic-Sortiment trieben die Beschleunigung. Die Vorhersage traf ein; die einzige Einschränkung war, dass der US-Segmentgewinn trotz starkem Umsatzwachstum aufgrund höherer Marketingausgaben (Molson-Coors-Partnerschaft) sank, was den Aktienkurs um ~5 % belastete – dies betraf jedoch die Marge, nicht das organische Wachstum. Quellen: uk.advfn.com/fevertree-h1-brand-revenue-rises-8, globalbankingandfinance.com/fever-tree-drinks-half-year-profit-rises, ca.investing.com/fevertree-h1-2026-sales-grow-shares-fall
Related Predictions
🍾 Beverages ✦ AI

Rémy Cointreau achieves more than 2.0 percent organic net sales growth year-on-year for full year FY2026/27 (April 2026 – March 2027) — confirmed by Rémy Cointreau press release or Bloomberg by June 30, 2027

Rémy Cointreau published its H1 FY2026/27 result on October 27, 2026: organic growth of +2.9 percent YoY for April–September 2026 — 90 basis points above this forecast's threshold. The company confirmed its FY2026/27 guidance ('gradual return to organic growth'). Q2 FY2026/27 (Jul–Sep): Cognac up 12 percent YoY. FY2025/26 full year: +0.2 percent organic ('in line with targets', Rémy IR, June 3, 2026). Achieving above 2.0 percent for the full year only requires H2 (Oct 2026–Mar 2027) to avoid a complete collapse — the 90-basis-point H1 buffer provides substantial safety margin. Risks: US demand weakness, Chinese Cognac tariffs, macro slowdown. Supporting: Rémy Martin premiumization strategy, confirmed guidance, strong Q2 momentum.

72%
Next Year · Predicted for 31. May 2027
🍾 Beverages ✦ AI

Total Champagne shipments 2026 fall below 280 million bottles — CIVC annual report by January 31, 2027

After the record of 322 million bottles (2021), Champagne shipments are in structural decline: ~319 million in 2022, ~299 million in 2023 (CIVC). Continued luxury weakness in China (export volume –27% YoY H1 2026), rising input costs, and saturated key markets (USA, France, UK) point to further contraction. At –5 to –7% p.a. decline (2022–2025 trend), 2026 volume would be approximately 262–271 million bottles — well below the 280 million threshold. No prediction market signal available. Confirmed via CIVC annual report or Reuters by January 31, 2027.

52%
Next Year · Predicted for 31. Jan 2027
🍾 Beverages ✦ AI

Monster Beverage Corporation (NASDAQ: MNST) beats Q3 FY2026 EPS consensus of 0.30 USD per share — earnings report November 5, 2026 after market close (confirmed by Monster Beverage Investor Relations or Bloomberg by November 6, 2026, 10:00 AM ET)

Analyst consensus for Q3 2026: EPS 0.2998 USD (~0.30 USD) with revenue of 2.49 billion USD (MarketBeat / TradingView, as of October 2026). Monster Beverage has beaten EPS consensus in a majority of recent quarters and continues to benefit from international market expansion in the energy drink segment. No active Polymarket or Kalshi market found for this event; beat probability estimated at ~65% based on historical beat rate and current consensus positioning.

65%
Next Week · Predicted for 5. Nov 2026